Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.00812107788851984 0.00812107788851984
Stock impact report

UPDATE 1-Eli Lilly's migraine treatment wins U.S. FDA approval [Reuters]

Eli Lilly and Company (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
Company Research Source: Reuters
Eli Lilly's migraine treatment wins U.S. FDA approval (Reuters) - The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co’s migraine drug, Reyvow. The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults. Lilly acquired Reyvow, formerly called lasmiditan, in a deal here Lilly said the price of Reyvow will be determined closer to the time of commercial availability. According to the Migraine Research Foundation, roughly 39 million Americans suffer from migraine headaches. The FDA advises patients not to drive or operate machinery for at least eight hours after taking Reyvow, as the drug causes dizziness and sedation. Reporting by Shivani Singh; Editing by Shinjini Ganguli Our Standards: The Thomson Reuters Trust Principles. Show less Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for LLY alerts
Opt-in for
LLY alerts

from News Quantified
Opt-in for
LLY alerts

from News Quantified